help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

A more recent version of this article appeared on September 1, 2007

Published online before print July 19, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ajpath.2007.061177v1
171/3/767    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freeman, C. M.
Right arrow Articles by Chensue, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeman, C. M.
Right arrow Articles by Chensue, S. W.
Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.061177


Accepted for publication May 21, 2007.


Article

CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity

Christine M. Freeman*, Jeffrey L. Curtis*{dagger}, and Stephen W. Chensue*{ddagger}{sect}@

From the Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine,* and Department of Pathology,{ddagger} University of Michigan Health System, Ann Arbor; and Pulmonary and Critical Care Medicine Section{dagger} and Pathology and Laboratory Medicine Service,{sect} VA Ann Arbor Healthcare System, Ann Arbor, Michigan

@ To whom correspondence should be addressed. E-mail: schensue{at}med.umich.edu.


   Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive disease associated with a cellular inflammatory response. CD8+ T cells are implicated in COPD pathogenesis, and their numbers significantly correlate with the degree of airflow limitation. Dendritic cells (DCs) are important sentinel immune cells, but little is known about their role in initiating and maintaining the CD8 T-cell response in COPD. To investigate the mechanisms for CD8+ T-cell recruitment to the lung, we used resected human lung tissue to analyze chemokine receptor expression by CD8+ T cells and chemokine production by CD1a+ DCs. Among 11 surveyed chemokine receptors, only CC chemokine receptor (CCR5), CXC chemokine receptor (CXCR) 3, and CXCR6 correlated with COPD severity as defined by criteria from the Global Initiative for Chronic Obstructive Lung Disease. The CD8+ T cells displayed a Tc1, CD45RA+ effector memory phenotype. CD1a+ DCs produced the respective ligands for CCR5 and CXCR3, CCL3 and CXCL9, and levels correlated with disease severity. CD1a+ DCs also constitutively expressed the CXCR6 ligand, CXCL16. In conclusion, we have identified major chemokine elements that potentially mediate CD8+ T-cell infiltration during COPD progression and demonstrated that CD1a+ mucosal-associated DCs may sustain CD8+ T-cell recruitment/retention. Chemokine targeting may prove to be a viable treatment approach.





This article has been cited by other articles:


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society for Investigative Pathology.